Cargando…
Linking Pharmacogenomic Information on Drug Safety and Efficacy with Ethnic Minority Populations
Numerous prescription drugs’ labeling contains pharmacogenomic (PGx) information to aid health providers and patients in the safe and effective use of drugs. However, clinical studies for such PGx biomarkers and related drug doses are generally not conducted in diverse ethnic populations. Thus, it i...
Autores principales: | Li, Dan, Xie, April Hui, Liu, Zhichao, Li, Dongying, Ning, Baitang, Thakkar, Shraddha, Tong, Weida, Xu, Joshua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7693750/ https://www.ncbi.nlm.nih.gov/pubmed/33113799 http://dx.doi.org/10.3390/pharmaceutics12111021 |
Ejemplares similares
-
Biochemical features and mutations of key proteins in SARS-CoV-2 and their impacts on RNA therapeutics
por: Zeng, Li, et al.
Publicado: (2021) -
Adaptability of AI for safety evaluation in regulatory science: A case study of drug-induced liver injury
por: Connor, Skylar, et al.
Publicado: (2022) -
Deep Learning on High-Throughput Transcriptomics to Predict Drug-Induced Liver Injury
por: Li, Ting, et al.
Publicado: (2020) -
DeepCarc: Deep Learning-Powered Carcinogenicity Prediction Using Model-Level Representation
por: Li, Ting, et al.
Publicado: (2021) -
Corrigendum: DeepCarc: Deep learning-powered carcinogenicity prediction using model-level representation
por: Li, Ting, et al.
Publicado: (2022)